Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 71288-137

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mitomycin (NDC 71288-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Mit05 0000 01)

Chemical structure of mitomycin, showing its molecular framework with multiple rings and functional groups including amine, methyl, and carbonyl groups as depicted in the diagram.*

FDA Label Image

5 mg Vial (Mit05 0000 02 V2)

Label for Mitomycin Injection, USP 5 mg per vial, a lyophilized powder for intravenous solution by Meitheal Pharmaceuticals Inc. The label includes a warning that the medication must be administered intravenously to avoid tissue damage. Contains detailed usage, storage, and handling instructions, plus manufacturer and lot information space.*

FDA Label Image

5 mg Carton (Mit05 0000 03 V2)

Packaging label for Mitomycin Injection, USP 5 mg per vial, a lyophilized powder for intravenous use. The label includes the NDC 71288-137-20, warnings about cytotoxicity, dosage instructions to administer intravenously, and storage conditions. It is labeled by Meitheal Pharmaceuticals Inc. and specifies a single-dose vial format.*

FDA Label Image

20 mg Vial (Mit05 0000 04 V2)

Label for Mitomycin for Injection, USP 20 mg per vial powder for intravenous solution by Meitheal Pharmaceuticals Inc. The single-dose vial includes warnings to avoid tissue damage and cautions that the drug is cytotoxic. The label details storage instructions, dosage precautions, and highlights that the product is sterile, nonpyrogenic, and preservative-free.*

FDA Label Image

20 mg Carton (Mit05 0000 05 V4)

Packaging label for Mitomycin for Injection, USP 20 mg per vial by Meitheal Pharmaceuticals Inc. The label indicates a single-dose vial intravenous powder for solution with warnings about cytotoxicity and administration to avoid tissue damage. The label includes preparation instructions, storage guidelines, a barcode, and manufacturing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.